Reports From the Field

Improving Nephropathy Screening in Appalachian Patients With Diabetes Using Practice-Wide Outreach


 

References

From West Virginia University, Morgantown, WV.

Abstract

Objective: To describe the strategies a family medicine clinic in Appalachia utilized to increase nephropathy screening rates as well as to explore the factors predictive of nephropathy screening in patients with diabetes.

Design: This quality improvement project targeted the points in the care process when patients are lost to follow-up for nephropathy screening.

Setting and participants: Patients with diabetes cared for by a primary care provider (PCP) at an academic family medicine practice in Appalachia from January 2018 to November 2018.

Interventions: Bulk orders for albumin-to-creatinine (ACR) testing and urine collection during clinic visit, enhanced patient communication through bulk communication reminders and individual patient outreach, and education of clinic providers.

Measurements: Demographic data and monthly nephropathy screening rates.

Results: The nephropathy screening rate increased by 6.2% during the project. Older patients living closer to the clinic who visited their PCP 3 or more times per year were the most likely to be screened.

Conclusion: Combining team-based interventions with quality control monitoring can significantly improve compliance with recommended nephropathy treatment and screening in rural patients with diabetes at a family medicine clinic.

Keywords: rural; kidney disease; albumin-to-creatinine ratio; electronic health record.

Pages

Recommended Reading

SGLT2 inhibitors for diabetes safe, effective in older adults
Journal of Clinical Outcomes Management
Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes
Journal of Clinical Outcomes Management
Carbohydrate restriction a viable choice for reversal of type 2 diabetes, expert says
Journal of Clinical Outcomes Management
Gout rates reduced with SGLT2 inhibitors
Journal of Clinical Outcomes Management
FDA warns of possible cancer risk with lorcaserin
Journal of Clinical Outcomes Management
Bariatric surgery is most effective early in the diabetes trajectory
Journal of Clinical Outcomes Management
Sarcopenia associated with increased cardiometabolic risk
Journal of Clinical Outcomes Management
FDA approves CV disease benefit for once-weekly semaglutide
Journal of Clinical Outcomes Management
Gestational diabetes: Treatment controversy rages on
Journal of Clinical Outcomes Management
Noninjectable modes of insulin delivery coming of age
Journal of Clinical Outcomes Management